Attention-deficit hyperactivity disorder (ADHD) is associated with substantial personal and
social impairments. Besides psychosocial interventions, current guidelines recommend a …

Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

This article reviews the efficacy of methylphenidate (MPH) for adult attention-
deficit/hyperactivity disorder (ADHD). A literature search identified double-blind placebo …

Objectives. This trial was performed to test the efficacy and safety of an extended-release
formulation of methylphenidate (MPH ER). Methods. A total of 162 adults with ADHD …

Recent research has demonstrated that attention-deficit/hyperactivity disorder (ADHD), one
of the most common mental disorders in childhood, continues into adulthood. In adulthood …

Background Methylphenidate (MPH), a psycho-stimulant, is the most widely administered
drug for the pharmacological management of patients with attention deficit hyperactivity …

Background: The efficacy of methylphenidate for adults with attention-deficit hyperactivity
disorder (ADHD) shows wide between-study variability, which yields heterogeneous results …

Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study
(COMPAS) was a prospective, randomized multicenter clinical trial, comparing …

Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent mental disorder of
childhood, which often persists in adulthood. Methylphenidate (MPH) is one of the most …

Attention-deficit/hyperactivity disorder (ADHD) is a chronic psychiatric disorder characterized
by hyperactivity and/or inattention and is often associated with a substantial impact on …